CHROMOGRANIN-A IN THE DIAGNOSIS OF PROSTATE CANCER
The principal marker of neuroendocrine differentiation (NED) is chromogranin A (HGA). The purpose of this work is to determine the role of NED in diseases of the prostate gland by the level of HGA.Materials and methods. The study included 304 men with various diseases of the prostate: BPH - 20; chro...
Saved in:
Main Authors: | A. V. Sivkov, N. G. Keshishev, G. D. Efremov, G. A. Kovchenko, A. A. Trudov, L. M. Nikonova, F. D. Romikh |
---|---|
Format: | Article |
Language: | Russian |
Published: |
QUASAR, LLC
2015-04-01
|
Series: | Исследования и практика в медицине |
Subjects: | |
Online Access: | https://www.rpmj.ru/rpmj/article/view/40 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis
by: Xiaoying Tang, et al.
Published: (2025-02-01) -
Is There a Relationship between the Staining Pattern of Classical Neuroendocrine Markers and Clinicopathological Findings in Neuroendocrine Tumors of the Appendix?
by: Merve CİN, et al.
Published: (2025-01-01) -
Co-modulation of a circular form of PCDH11Y during neuroendocrine differentiation of prostate cancer
by: Giovanni Pecoraro, et al.
Published: (2025-02-01) -
Evaluating the usefulness of plasma chromogranin A measurement in cyclic ACTH-dependent Cushing’s syndrome
by: Keisuke Kakizawa, et al.
Published: (2024-10-01) -
A case of de novo neuroendocrine prostate cancer presented with elevated level of serum CEA carrying BRCA2 mutation: case report and literature review
by: Weizhe Han, et al.
Published: (2025-01-01)